about
Human primary immunodeficiencies causing defects in innate immunity.Mobile health applications in clinical practice: pearls, pitfalls, and key considerations.Case 3: Persistent Fever in an 8-month-old Boy.Primum non nocere-first do no harm. And then feed peanut.Rifampin hypersensitivity in a 2-year-old child with successful rapid oral desensitization.Vasculitis masquerading as drug allergy: thinking outside the ‘adult’ box of possible diagnoses.Rifampin hypersensitivity in a two year-old child with successful rapid oral desensitization.IRAK-4 deficiency as a cause for familial fatal invasive infection by Streptococcus pneumoniae.Limitation of TREC-based newborn screening for ZAP70 Severe Combined Immunodeficiency.THE PHENOTYPE OF SEVERE PRESCHOOL ASTHMATICS AND THEIR RESPONSE TO ADD-ON THERAPY.Early introduction of foods to prevent food allergyAsthmaExtended analysis of parent and child confidence in recognizing anaphylaxis and using the epinephrine autoinjector during oral food challengesEpinephrine auto injector administration by parents or patients for anaphylaxis during supervised oral food challenges and assessment of confidenceInterstitial lung disease in infancy: an unusual presentation of CD40 ligand deficiencyImpact of supervised epinephrine autoinjector administration during food challenges on parent confidenceFirst Real-World Safety Analysis of Preschool Peanut Oral ImmunotherapyTiming of introduction of allergenic solids for infants at high risk
P50
Q38152656-D7EE1A02-FF73-44E0-B69D-3C6FA91637E6Q38921400-DC16C281-E2B1-4C08-ACF7-3630C7A2D829Q40067163-5E3DA974-F639-46FF-AC6C-BE34B7583488Q41862056-027E3E93-59EA-4A16-B71B-CF823A50876EQ44400798-467AB625-67C6-412E-9517-C5BDE5F7F023Q46671764-A63CA02D-8F83-4FF0-A07A-6F175F711B10Q47126790-6EE7B08A-D7EF-446E-80D2-8D8DEEC9CCF7Q50433824-DD05C26F-830E-4B5B-A3C9-36F9C650699AQ53053269-3702055A-E41D-4FC2-85E0-DBED9D1B812CQ55196735-483D38FC-8030-4056-845D-B26C641CD978Q57111878-A82C27CD-9001-40E9-84AE-9E19499481E0Q57111941-C46A3DB5-5FFA-4C17-97EC-C6DF6C762926Q57186934-4BA337ED-B4B4-44D7-BB20-1A06F902D765Q59322805-80B7AF7F-A8D2-4768-89DB-7B705D4140ECQ60338671-1650DA14-8442-46E9-8BD3-FCEB26422050Q89385585-0E16BA0D-AAD3-4D60-B3C8-9E4C477B614DQ90016437-4C6FB246-C89C-46F2-A9B5-00D57207CEEAQ92129577-BF790D56-3CE1-4820-A03E-B840308F6B1B
P50
description
researcher ORCID ID = 0000-0003-3825-8202
@en
wetenschapper
@nl
name
Kyla J Hildebrand
@ast
Kyla J Hildebrand
@en
Kyla J Hildebrand
@nl
type
label
Kyla J Hildebrand
@ast
Kyla J Hildebrand
@en
Kyla J Hildebrand
@nl
prefLabel
Kyla J Hildebrand
@ast
Kyla J Hildebrand
@en
Kyla J Hildebrand
@nl
P108
P106
P31
P496
0000-0003-3825-8202